ASND logo

Ascendis Pharma A/S (ASND) Accounts Payable

Annual Accounts Payable

$100.30 M
-$4.23 M-4.05%

December 31, 2024

Summary

Performance

1-Year Change

-4.05%

3-Year Change

+49.1%

5-Year Change

+222.51%

15-Year Change

+379.57%

ASND Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.17%
ASND annual accounts payable is higher than 90.17% of companies in Healthcare sector

High & Low

All-time High

$108.35 M
ASND annual accounts payable is currently -7.42% below its historical high of $108.35 million

3-Year Low

$67.27 M
ASND annual accounts payable is currently +49.10% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ASND previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ASND next annual earnings announcement has not yet been scheduled

OtherASNDbalance sheetmetrics:

Annual Accounts Receivable

$173.03 M
ASND annual accounts receivable is $173.03 million

Annual Total Liabilities

$1.34 B
ASND annual total liabilities is $1.34 billion

Annual Total Assets

$1.23 B
ASND annual total assets is $1.23 billion

Annual Current Assets

$1.10 B
ASND annual total current assets is $1.10 billion

Quarterly Accounts Payable

$100.30 M
+$16.24 M+19.32%

December 31, 2024

Summary

Performance

3-Month Change

+19.32%

1-Year Change

-5.98%

3-Year Change

-5.98%

5-Year Change

-5.98%

ASND Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.82%
ASND quarterly accounts payable is higher than 90.82% of companies in Healthcare sector

High & Low

All-time High

$143.33 M
ASND quarterly accounts payable is currently -30.02% below its historical high of $143.33 million

3-Year Low

$67.27 M
ASND quarterly accounts payable is currently +49.10% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ASND previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
ASND next earnings announcement is scheduled for May 2, 2025

OtherASNDbalance sheetmetrics:

Quarterly Accounts Receivable

$173.03 M
ASND quarterly accounts receivable is $173.03 million

Quarterly Total Liabilities

$1.34 B
ASND quarterly total liabilities is $1.34 billion

Quarterly Total Assets

$1.23 B
ASND quarterly total assets is $1.23 billion

Quarterly Current Assets

$1.10 B
ASND quarterly total current assets is $1.10 billion

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

ASND Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.0%-6.0%
3 y3 years+49.1%-6.0%
5 y5 years+222.5%-6.0%

ASND Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-7.4%+49.1%-30.0%+49.1%
5 y5-year-7.4%+272.4%-30.0%+272.4%
alltimeall time-7.4%+2975.3%-30.0%+2782.5%

Ascendis Pharma A/S Accounts Payable History

DateAnnualQuarterly
Dec 2024
$100.30 M(-4.0%)
$100.30 M(+19.3%)
Sep 2024
-
$84.07 M(-21.2%)
Jun 2024
-
$106.68 M(+4.5%)
Mar 2024
-
$102.08 M(-2.3%)
Dec 2023
$104.53 M(-3.5%)
$104.53 M(-18.8%)
Sep 2023
-
$128.66 M(-3.1%)
Jun 2023
-
$132.71 M(-7.4%)
Mar 2023
-
$143.33 M(+32.3%)
Dec 2022
$108.35 M(+61.1%)
$108.35 M(+28.0%)
Sep 2022
-
$84.63 M(+8.0%)
Jun 2022
-
$78.33 M(-0.7%)
Mar 2022
-
$78.89 M(+17.3%)
Dec 2021
$67.27 M(+149.8%)
$67.27 M(-24.2%)
Sep 2021
-
$88.70 M(+68.6%)
Jun 2021
-
$52.61 M(-17.1%)
Mar 2021
-
$63.46 M(+135.6%)
Dec 2020
$26.93 M(-13.4%)
$26.93 M(-39.8%)
Sep 2020
-
$44.74 M(+26.0%)
Jun 2020
-
$35.51 M(+18.0%)
Mar 2020
-
$30.08 M(-3.3%)
Dec 2019
$31.10 M
$31.10 M(+16.8%)
Sep 2019
-
$26.64 M(+10.3%)
DateAnnualQuarterly
Jun 2019
-
$24.14 M(+11.8%)
Mar 2019
-
$21.60 M(-4.3%)
Dec 2018
$22.58 M(+8.0%)
$22.58 M(-37.4%)
Sep 2018
-
$36.05 M(-14.9%)
Jun 2018
-
$42.33 M(+97.2%)
Mar 2018
-
$21.47 M(+2.6%)
Dec 2017
$20.92 M(+51.3%)
$20.92 M(-9.4%)
Sep 2017
-
$23.08 M(+29.9%)
Jun 2017
-
$17.77 M(-4.9%)
Mar 2017
-
$18.69 M(+35.2%)
Dec 2016
$13.83 M(+51.0%)
$13.83 M(+8.1%)
Sep 2016
-
$12.78 M(+13.8%)
Jun 2016
-
$11.24 M(+18.9%)
Mar 2016
-
$9.45 M(+3.2%)
Dec 2015
$9.15 M(+51.9%)
$9.15 M(+51.0%)
Sep 2015
-
$6.06 M(-22.5%)
Jun 2015
-
$7.82 M(+32.8%)
Mar 2015
-
$5.89 M(-2.3%)
Dec 2014
$6.03 M(+73.2%)
$6.03 M(+56.0%)
Sep 2014
-
$3.86 M(+11.0%)
Dec 2013
$3.48 M(+3.9%)
$3.48 M
Dec 2012
$3.35 M(+2.7%)
-
Dec 2011
$3.26 M
-

FAQ

  • What is Ascendis Pharma A/S annual accounts payable?
  • What is the all time high annual accounts payable for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S annual accounts payable year-on-year change?
  • What is Ascendis Pharma A/S quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S quarterly accounts payable year-on-year change?

What is Ascendis Pharma A/S annual accounts payable?

The current annual accounts payable of ASND is $100.30 M

What is the all time high annual accounts payable for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high annual accounts payable is $108.35 M

What is Ascendis Pharma A/S annual accounts payable year-on-year change?

Over the past year, ASND annual accounts payable has changed by -$4.23 M (-4.05%)

What is Ascendis Pharma A/S quarterly accounts payable?

The current quarterly accounts payable of ASND is $100.30 M

What is the all time high quarterly accounts payable for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high quarterly accounts payable is $143.33 M

What is Ascendis Pharma A/S quarterly accounts payable year-on-year change?

Over the past year, ASND quarterly accounts payable has changed by -$6.38 M (-5.98%)